# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Calidi Biotherapeutics (AMEX:CLDI) reported quarterly losses of $(1.99) per share which missed the analyst consensus estimate o...